327 related articles for article (PubMed ID: 29202299)
21. [The anti-proliferative and anti-inflammatory mechanisms of JAK1 inhibitor SHR0302 versus Ruxolitinib in SET2 cell line and primary cells].
Yang AY; Liu JQ; Cai YN; Fang MY; Yang L; Chen M; Li B; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2019 Dec; 40(12):1003-1007. PubMed ID: 32023730
[No Abstract] [Full Text] [Related]
22. The antagonist of the JAK-1/STAT-1 signaling pathway improves the severity of cerulein-stimulated pancreatic injury via inhibition of NF-κB activity.
Chen P; Huang L; Zhang Y; Qiao M; Yao W; Yuan Y
Int J Mol Med; 2011 May; 27(5):731-8. PubMed ID: 21369693
[TBL] [Abstract][Full Text] [Related]
23. The promise of Janus kinase inhibitors in the treatment of hematological malignancies.
Senkevitch E; Durum S
Cytokine; 2017 Oct; 98():33-41. PubMed ID: 28277287
[TBL] [Abstract][Full Text] [Related]
24. Anti-Inflammatory Effects of
Kim YJ; Lee JY; Kim HJ; Kim DH; Lee TH; Kang MS; Park W
Nutrients; 2018 May; 10(5):. PubMed ID: 29883374
[TBL] [Abstract][Full Text] [Related]
25. Utility of Ruxolitinib in a Child with Chronic Mucocutaneous Candidiasis Caused by a Novel STAT1 Gain-of-Function Mutation.
Bloomfield M; Kanderová V; Paračková Z; Vrabcová P; Svatoň M; Froňková E; Fejtková M; Zachová R; Rataj M; Zentsová I; Milota T; Klocperk A; Kalina T; Šedivá A
J Clin Immunol; 2018 Jul; 38(5):589-601. PubMed ID: 29934865
[TBL] [Abstract][Full Text] [Related]
26. Anti-inflammatory potential of Patrineolignan B isolated from Patrinia scabra in LPS-stimulated macrophages via inhibition of NF-κB, AP-1, and JAK/STAT pathways.
Lee HH; Jang E; Kang SY; Shin JS; Han HS; Kim TW; Lee DH; Lee JH; Jang DS; Lee KT
Int Immunopharmacol; 2020 Sep; 86():106726. PubMed ID: 32593157
[TBL] [Abstract][Full Text] [Related]
27. CP690,550 inhibits oncostatin M-induced JAK/STAT signaling pathway in rheumatoid synoviocytes.
Migita K; Komori A; Torigoshi T; Maeda Y; Izumi Y; Jiuchi Y; Miyashita T; Nakamura M; Motokawa S; Ishibashi H
Arthritis Res Ther; 2011 May; 13(3):R72. PubMed ID: 21548952
[TBL] [Abstract][Full Text] [Related]
28. JAK-STAT signaling in the therapeutic landscape of myeloproliferative neoplasms.
O'Sullivan JM; Harrison CN
Mol Cell Endocrinol; 2017 Aug; 451():71-79. PubMed ID: 28167129
[TBL] [Abstract][Full Text] [Related]
29. Mollugin inhibits the inflammatory response in lipopolysaccharide-stimulated RAW264.7 macrophages by blocking the Janus kinase-signal transducers and activators of transcription signaling pathway.
Zhu ZG; Jin H; Yu PJ; Tian YX; Zhang JJ; Wu SG
Biol Pharm Bull; 2013; 36(3):399-406. PubMed ID: 23318249
[TBL] [Abstract][Full Text] [Related]
30. Anti-myeloma effects of ruxolitinib combined with bortezomib and lenalidomide: A rationale for JAK/STAT pathway inhibition in myeloma patients.
de Oliveira MB; Fook-Alves VL; Eugenio AIP; Fernando RC; Sanson LFG; de Carvalho MF; Braga WMT; Davies FE; Colleoni GWB
Cancer Lett; 2017 Sep; 403():206-215. PubMed ID: 28645562
[TBL] [Abstract][Full Text] [Related]
31. Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations.
Chen J; Zhang Y; Petrus MN; Xiao W; Nicolae A; Raffeld M; Pittaluga S; Bamford RN; Nakagawa M; Ouyang ST; Epstein AL; Kadin ME; Del Mistro A; Woessner R; Jaffe ES; Waldmann TA
Proc Natl Acad Sci U S A; 2017 Apr; 114(15):3975-3980. PubMed ID: 28356514
[TBL] [Abstract][Full Text] [Related]
32. Downregulated SOCS1 expression activates the JAK1/STAT1 pathway and promotes polarization of macrophages into M1 type.
Liang YB; Tang H; Chen ZB; Zeng LJ; Wu JG; Yang W; Li ZY; Ma ZF
Mol Med Rep; 2017 Nov; 16(5):6405-6411. PubMed ID: 28901399
[TBL] [Abstract][Full Text] [Related]
33. Janus kinase-signal transducer and activator of transcription mediates phosphatidic acid-induced interleukin (IL)-1beta and IL-6 production.
Lee C; Lim HK; Sakong J; Lee YS; Kim JR; Baek SH
Mol Pharmacol; 2006 Mar; 69(3):1041-7. PubMed ID: 16354768
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic effect of JAK1/2 blockade on the manifestations of hemophagocytic lymphohistiocytosis in mice.
Maschalidi S; Sepulveda FE; Garrigue A; Fischer A; de Saint Basile G
Blood; 2016 Jul; 128(1):60-71. PubMed ID: 27222478
[TBL] [Abstract][Full Text] [Related]
35. Blockade of Janus kinase-2 signaling ameliorates mouse liver damage due to ischemia and reperfusion.
Freitas MC; Uchida Y; Zhao D; Ke B; Busuttil RW; Kupiec-Weglinski JW
Liver Transpl; 2010 May; 16(5):600-10. PubMed ID: 20440769
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of IL-6 and IL-10 signaling and Stat activation by inflammatory and stress pathways.
Ahmed ST; Ivashkiv LB
J Immunol; 2000 Nov; 165(9):5227-37. PubMed ID: 11046056
[TBL] [Abstract][Full Text] [Related]
37. Signal transducer and activator of transcription (STAT) 1 and STAT3 are expressed in the human ovary and have Janus kinase 1-independent functions in the COV434 human granulosa cell line.
Frost ER; Ford EA; Peters AE; Reed NL; McLaughlin EA; Baker MA; Lovell-Badge R; Sutherland JM
Reprod Fertil Dev; 2020 Aug; 32(12):1027-1039. PubMed ID: 32758351
[TBL] [Abstract][Full Text] [Related]
38. The Effect of JAK Inhibitor on the Survival, Anagen Re-Entry, and Hair Follicle Immune Privilege Restoration in Human Dermal Papilla Cells.
Kim JE; Lee YJ; Park HR; Lee DG; Jeong KH; Kang H
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32698510
[TBL] [Abstract][Full Text] [Related]
39. Patriscabrin F from the roots of Patrinia scabra attenuates LPS-induced inflammation by downregulating NF-κB, AP-1, IRF3, and STAT1/3 activation in RAW 264.7 macrophages.
Shin JS; Kang SY; Lee HH; Kim SY; Lee DH; Jang DS; Lee KT
Phytomedicine; 2020 Mar; 68():153167. PubMed ID: 32028186
[TBL] [Abstract][Full Text] [Related]
40. Bicarbonate enhances the inflammatory response by activating JAK/STAT signalling in LPS + IFN-γ-stimulated macrophages.
Kawakami T; Koike A; Maehara T; Hayashi T; Fujimori K
J Biochem; 2020 Jun; 167(6):623-631. PubMed ID: 31960927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
